Olympus 2008 Annual Report Download - page 9

In the gastrointestinal endoscope field, domestic
and overseas sales of high-resolution HDTV endo-
scope systems remained firm. This was due to the
product’s special function that enables observation
to be conducted using specific light spectra; during
endoscopic observation, Narrow Band Imaging
(NBI) enhances visualization of the capillary
network morphology.
Furthermore, Olympus acquired Gyrus Group
PLC, a UK-based medical equipment company, in
February 2008 to accelerate the reinforcement
of its surgical products business. By integrating
Gyrus’ strengths in minimally invasive procedures,
Olympus will enhance its business in the uro-
logical, gynecological and otological fields. For
Olympus, Gyrus’ extensive business network in
North America was particularly attractive. Deriving
synergistic effects from its business integration
with Gyrus, Olympus will seek to grow as a compre-
hensive endoscope device manufacturer.
Life Science Business:
Nurturing Businesses for the Next Generation
> The Life Science Business experienced an increase
in revenue due to strong overseas sales in the
micro-imaging (microscopes) and diagnostic sys-
tem fields. However, earnings declined as a result
of forward-looking investment in new technological
development. Taking this situation seriously, we
will endeavor to expand business to see a return on
our investment.
In recent years, translational research, which
can serve as a bridge between basic research and
clinical care, has become increasingly important in
the Life Science Business. Based on the findings
of such research, Olympus is aiming to bring to
fruition next-generation medical care, including
personalized and regenerative medicines.
Sales of digital SLR cameras grew year on
year, reflecting the successful boost to Olympus’
market presence achieved by releasing three new
products, ranging from entry-level to professional
models. We also launched unique digital compact
cameras with excellent waterproof and shock
resistance to gain a competitive edge. Together
with these developments, our structural reforms,
including the establishment of product and
operational platforms by focusing on thorough
inventory control and the use of common parts
and components from the development phase,
achieved favorable results.
In the fiscal year ending March 31, 2009,
Olympus anticipates decreased revenue and earn-
ings due to the impact of the strong yen. However,
we expect digital camera and optical component
sales volume to increase. In the medium term, we
aim to enhance overseas sales of digital compact
cameras and increase our share of the digital SLR
camera market. Simultaneously, we will vigorously
push ahead with the profit-oriented reforms to our
management structure.
Medical Systems Business:
Expanding to Offer Full Coverage,
from Early Detection to Treatment
> In fiscal 2008, the Medical Systems Business
recorded increased revenue and earnings due to
robust sales—both in Japan and overseas—of
endoscope systems that enable observation using
specific light spectra, surgical endoscopes and
endotherapy devices. Our mission in this business
is to overcome social issues surrounding the
early detection and treatment of cancer as well
as minimally invasive diagnosis and procedures.
While developing new products and spearheading
the market as a leading endoscope company, we
will contribute to the development of medical
technology by offering a comprehensive range of
endoscopes, covering examination, diagnosis and
treatment.
OLYMPUS 2008 7